Using Burst Deep Brain Stimulation to Treat Neuropathic Pain
Official title: Burst-Deep Brain Stimulation of the Thalamus for Neuropathic Facial Pain and Central Poststroke Pain: a Prospective, Randomized Cross-over Feasibility Trial
Run by Insel Gruppe AG, University Hospital Bern · NCT05204472 · Data updated 2026-11-12
This study is testing a new way of using brain stimulation to see if it can help people with chronic nerve pain feel better compared to the usual method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 1 site (Bern) |
| Status | Recruiting |
| Started | September 1, 2022 |
| Main results expected | August 2026 |
| Study ends | February 2027 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT05204472 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-75 with chronic unilateral neuropathic pain lasting over 12 months, resistant to standard pain medications.
✕Probably not a fit
Patients with significant cognitive impairments or psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical investigation aims to evaluate the effectiveness of Burst Deep Brain Stimulation (DBS) of the thalamus compared to traditional tonic DBS in reducing pain intensity in patients suffering from chronic neuropathic pain, specifically Central Post-stroke Pain (CPSP) and Neuropathic Facial Pain (NFP). The study involves implanting electrodes in the brain to deliver therapeutic electrical currents, utilizing a novel burst stimulation paradigm that has shown promise in spinal cord stimulation for pain relief. Participants will be monitored for changes in pain levels over time, providing insights into the efficacy of this innovative approach.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce chronic pain for patients suffering from neuropathic pain conditions, improving their quality of life.
How similar studies have gone: While burst stimulation has shown success in spinal cord stimulation, its application in deep brain stimulation for neuropathic pain is novel and has not been systematically evaluated before.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed informed consent * Age 18-75 years * Patients suffering from chronic (duration \> 12 months) unilateral neuropathic pain caused by an ischemic or haemorrhagic cerebral stroke or * Patients suffering from chronic (duration \> 12 months) unilateral neuropathic facial pain due to one of the following causes: 1. post-herpes-zoster-neuralgia, 2. posttraumatic, neuropathic facial pain, 3. atypical trigeminal neuralgia after surgical intervention * Severe baseline pain intensity (VAS score \> 6/10) considered as resistant to medication specific to neuropathic pain at sufficient doses and durations (including at least antiepileptics and antidepressants) Exclusion Criteria: * Significant cognitive impairment (total MOCA score \< 1.5 standard deviations from age- and education adapted mean values), * DSMIV axis I or II psychiatric disorder * Relevant psychosocial risk factors (any of): history of other chronic pain syndrome, pain catastrophizing, substance abuse, secondary gain * Contra-indication to surgery, anesthesia, or MRI * Known or suspected non-compliance or inability to operate the DBS system * Woman with childbearing potential * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia. etc. of the subject * Participation in another interventional clinical trial within 30 days prior to this trial or during the trial * Previous enrollment into the current trial * Enrolment of the investigator's family members, employees, and other dependent persons * Patients who are planned to undergo diathermy, electroshock therapy or transcranial magnetic stimulation (TMS) * Patients with implanted electric devices (i.e. cardiac defibrillator, pacemaker) * Patients who are at poor surgical risk (i.e. patients with multiple severe illnesses or active general infections)
Where it's running
-
Dep. of Neurosurgery, Bern University Hospital
Bern, Switzerland Recruiting
Study contacts
- Principal investigator: Andreas Nowacki, MD — Insel Gruppe AG, University Hospital Bern
- Study coordinator: Andreas Nowacki, MD
- Email: andreas.nowacki@insel.ch
- Phone: +41 31 6320014
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Extended-release Pregabalin for nerve pain from diabetes or shingles
This phase 3 study tests an extended-release form of pregabalin to see if it reduces nerve-pain symptoms in adults with diabetic neuropathy or postherpetic neuralgia.
-
High-Intensity Peripheral Magnetic Stimulation for Traumatic Nerve Injury
This study tests whether adding high-intensity peripheral magnetic stimulation to a structured exercise program can reduce pain and improve function for adults with a traumatic peripheral nerve injury.
-
Hematological clues and how patients respond to nerve blocks for neuropathic pain
This study looks at blood inflammation markers to see if they relate to how well people with neuropathic pain respond to sympathetic nerve blocks.
-
Pain relief after stroke: spinal cord stimulation plus medicines vs medicines alone
This study tests whether adding spinal cord stimulation to standard pain medications helps people with central post-stroke pain see better pain relief than medications alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.